Press "Enter" to skip to content

New patent for Horizon Pharma drug PROCYSBI

0
Copyright © DrugPatentWatch. Originally published at New patent for Horizon Pharma drug PROCYSBI

Annual Drug Patent Expirations for PROCYSBI
Annual Drug Patent Expirations for PROCYSBI

Procysbi is a drug marketed by Horizon Pharma Usa and is included in two NDAs. There are sixteen patents protecting this drug.

Drug patent litigation for PROCYSBI.

This drug has forty-five patent family members in thirty-three countries.

The generic ingredient in PROCYSBI is cysteamine bitartrate. Additional details are available on the cysteamine bitartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Horizon Pharma drug PROCYSBI
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions